DrABC: Deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data

Identifying breast cancer patients with DNA repair pathway-related germline pathogenic variants (GPVs) is important for effectively employing systemic treatment strategies and risk-reducing interventions.